Related Experiment Videos

Prognostic indicators in children with IgA nephropathy--report of the Southwest Pediatric Nephrology Study Group

R J Hogg1, F G Silva, R J Wyatt

  • 1Department of Pediatrics, Baylor University Medical Center, Dallas, TX 75246.

Insights

IgA nephropathy (IgAN) in children can lead to end-stage renal disease (ESRD) more often than previously thought. Key risk factors for ESRD in pediatric IgAN include glomerular sclerosis, hypertension, and proteinuria.

Area of Science:

  • Pediatric Nephrology
  • Immunology
  • Renal Pathology

Background:

  • IgA nephropathy (IgAN) is a common cause of glomerulonephritis in children.
  • Understanding prognostic factors for IgAN progression to end-stage renal disease (ESRD) is crucial for early intervention.
  • Previous studies primarily focused on adult populations, necessitating pediatric-specific data.

Purpose of the Study:

  • To identify clinical and pathological predictors of ESRD in a cohort of children and adolescents with IgAN.
  • To assess the incidence of ESRD in pediatric IgAN patients.
  • To validate prognostic markers in a pediatric population.

Main Methods:

  • Retrospective review of clinical and pathological data from 218 pediatric IgAN patients across 13 centers.
  • Detailed analysis of 80 patients with a minimum 4-year follow-up.
  • Statistical analysis including univariate and stepwise linear discriminant analysis to identify ESRD predictors.

Main Results:

  • Seven variables significantly predicted ESRD: glomerular sclerosis, black race, hypertension, proteinuria, age at presentation, crescents, and male sex.
  • Glomerular sclerosis, particularly when affecting 20% or more of glomeruli, was a strong predictor.
  • The developed discriminant function accurately predicted ESRD in 95% of subjects.

Conclusions:

  • ESRD occurs more frequently in American children with IgAN than previously recognized.
  • Risk factors for ESRD in pediatric IgAN mirror those found in adult studies, emphasizing glomerular sclerosis, proteinuria, and hypertension.
  • These findings highlight the need for vigilant monitoring and risk stratification in pediatric IgAN patients.

Related Concept Videos